SMILE vs. LASIK Using Contoura With Phorcides

NCT05844397 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2025-02-27

No results posted yet for this study

Summary

Subjects will undergo SMILE surgery in one eye and LASIK using Contoura with Phorcides on the contralateral eye to correct myopia.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

WaveLight EX500 Excimer Laser System

LASIK Refractive Surgery Using Contura with Phorcides

DEVICE

VisuMax Surgical Laser

SMILE Refractive Surgery

Sponsors & Collaborators

  • 59th Medical Wing

    lead FED

Principal Investigators

  • Charisma B Evangelista, MD · 59th Medical Wing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-09
Primary Completion
2024-05-14
Completion
2024-05-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05844397 on ClinicalTrials.gov